Healing Together, Every Step of the Way

Therapies Include:

Putting patients first is the core principle at California Infusion Therapy Center. Our commitment revolves around prioritizing your care, safety, and comfort in every aspect of our services.

Our Infusion Center was established with the conviction that individuals requiring routine infusions deserve a superior environment compared to impersonal and inconvenient hospital infusion centers..

WHO WE SERVE

We have meticulously crafted the entire experience with patients grappling with complex, chronic conditions in mind. Here, you receive top-notch care in a serene and comfortable atmosphere. Our tailored service, exclusive infusion suites, and vigilant monitoring by our medical team empower patients to effectively manage their autoimmune conditions.
Our empathetic and seasoned Infusion nurses specialize in treating a spectrum of autoimmune disorders and various other conditions, including:

If you undergo regular infusions for a condition not listed here, please Contact Us.

Therapies We Offer

California Infusion Therapy is one of the leading providers of adult and pediatric services, and we offer a wide range of infusion therapies. We administer over 45 brands and biosimilars pharmaceuticals and biologics from US-based suppliers. Additionally, we monitor new drug approvals to ensure that our patients have access to the broadest range of infused therapies available

INJECTION TREATMENTS

Amvuttra
Amvuttra was created for people who suffer from hereditary ATTR (hATTR) amyloidosis. By taking this medication, patients can achieve a significant improvement in nerve function and their overall quality of life. In addition, this medication only has to be taken once every three months. hATTR amyloidosis is a progressive condition that happens because of a mutation in the transthyretin (TTR) gene. This rare disorder can negatively impact the nerves, heart, and digestive system. In addition, some people may suffer from blurred vision, kidney dysfunction, and glaucoma. Amvuttra can help by reducing the amount of TTR protein your liver makes. As a result, your amyloid deposits are decreased. This can lead to fewer polyneuropathy symptoms. Every three months, you will receive Amvuttra as a subcutaneous injection. It can be given in your thighs, upper arm, or abdomen. Although it can occasionally reduce your vitamin A levels, no premedications or lab work are generally required before taking Amvuttra.
Fasenra
Fasenra is intended for people who have eosinophilic asthma. You might have eosinophilic asthma if you often need to use a rescue inhaler to control your asthma or frequently end up in the emergency room because of asthma attacks. Likewise, needing oral steroids or waking up at night because of asthma symptoms could be an indication of eosinophilic asthma. Eosinophils are a kind of white blood cell in your immune system. If you have eosinophilic asthma, you have too many eosinophils. This causes excessive inflammation and increased asthma symptoms. A simple blood test can show if you have elevated levels of eosinophils. If you are a candidate for Fasenra, you can begin taking one injection of this drug every eight weeks. You shouldn’t use this drug if you are allergic to any of the ingredients in Fasenra or benralizumab. While taking Fasenra, you may experience an allergic reaction or other side effects. If you experience any symptoms while taking this medication, you should talk to your doctor about them right away.
Gammagard (both IV & Inj)
Gammagard is made from human plasma for patients who suffer from primary immunodeficiency. It is available for people who are 2 years old or older. This ready-to-use medication consists of immunoglobulin G (IgG) antibodies, which can help fight off diseases. When you take this medication, it can temporarily boost the number of antibodies in your body for fighting infections. You can take this as an intravenous (IV) or subcutaneous (SubQ) medication. Over the last 15 years, Gammagard has been the most prescribed Ig in the United States. As an IV medication, you would take Gammagard every three to four weeks. If you take this medication as a SubQ injection, you would have to take it once a week. As an injection, it may be injected into up to eight spots during each treatment dose. Severe allergic infections, decreased kidney function, and other side effects can occur. Discuss the risks and benefits of this medication with your doctor before you take it.
Gammagard Liquid (both IV & Inj)
Gammagard Liquid can be given as an intravenous (IV) medicine and an injection. You should tell your doctor about your current medical conditions and if you are pregnant or nursing before you take this medication. If you decide to take it as an IV medication, you will need to go to an infusion center every three to four weeks. For Gammagard injections, you will need to go to the treatment center every week.
Leqvio
Leqvio can help people who want to lower their bad cholesterol (LDL). This medication is typically prescribed for people who are already taking a statin and have a history of heart disease. In addition, you should also adopt a heart-healthy diet. In clinical studies, people were able to lower their cholesterol by 50% after taking Leqvio and a statin. More importantly, they were able to keep their cholesterol down during the entire dosing interval. By taking this medication, you can help your body naturally remove bad cholesterol. Initially, you will take one dose followed by a second starter dose three months later. Afterward, your maintenance doses will occur every six months. Some people have a reaction to their injections. In clinical studies, the most common side effects of this medication were injection site reactions, urinary tract infections, chest colds, leg pain, arm pain, joint pain, diarrhea, and shortness of breath.
Stelara (Injection)
Stelara can be given to adults who have Crohn’s disease or ulcerative colitis. It can also treat children over the age of six and adults who have psoriasis or psoriatic arthritis. Stelara works by impacting the way your immune system functions. In clinical trials, it was found to help patients who had problems with previous medications. The majority of patients were able to achieve rapid relief from Crohn’s disease after just one dose of Stelara. For ulcerative colitis and Crohn’s disease, the first dose of Stelara is an infusion. Eight weeks later, you will be given an injection of Stelara. Afterward, you will receive an injection every eight weeks. With adult psoriasis patients, the initial doses are at zero weeks and four weeks. Following this, the doses will occur every 12 weeks. Pediatric patients have the same dosage schedule as adults, but the dose size is based on their weight.
Xolair
Xolair can treat allergic asthma in adults and children who are over the age of 6. It can also treat chronic hives in patients over the age of 12. Additionally, adults who have nasal polyps can use Xolair for symptom relief. If you suffer from asthma, you will most likely receive your injection every two or four weeks. For nasal polyps, Xolair is also prescribed every two to four weeks. Patients who have chronic hives with an unknown cause will receive their injection every four weeks. At the moment, Xolair is the only drug approved by the Food and Drug Administration (FDA) to treat allergic asthma. Once patients start taking Xolair, they can enjoy significantly decreased asthma attacks. To date, more than 305,000 patients have used this medication for allergic asthma. This medication works by focusing on immunoglobulin E (IgE). Because IgE is the underlying reason why people suffer from allergic asthma, this can significantly improve symptoms. Xolair can capture IgE in your body, so it can’t lead to an asthma attack.
Gammagard S/D (both IV & Inj)
Gammagard is made out of immunoglobulin G (IgG) antibodies, which are derived from human plasma. Afterward, this medication is turned into a liquid for patients who have primary immunodeficiency. You can take this medication as an intravenous (IV) treatment or an injection. Gammagard is given as a weekly injection. If you choose the IV option, you will need to get an infusion every three or four weeks.
Nucala
If you suffer from eosinophilic asthma, you can be given Nucala injections as an add-on medication. This maintenance treatment is designed to be a part of your ongoing treatment plan, so it isn’t intended for acute asthma attacks. You may have severe asthma if you are frequently using your rescue inhaler, wheezing, or coughing. If you are taking asthma medications and still wake up at night with difficulty breathing, you may need extra help. You can talk to your doctor to see if a diagnosis of eosinophilic asthma is accurate for you. Eosinophils are white blood cells. When you have too many eosinophils, it can cause extra lung inflammation and more asthma attacks. You can easily see if you have eosinophilic asthma by getting a blood test to check your eosinophil levels. If you have severe asthma, you will typically receive an injection of Nucala every four weeks. For other conditions, the dosage schedule can vary.
Subcutaneous immunoglobulins
Subcutaneous immunoglobulins (SCIg) are given via a slow injection. This injection is called subcutaneous because it is given in the fatty tissue under your skin. Depending on the medication, you will typically get SCIg one to three times per week. SCIg is used for diverse illnesses, like chronic inflammatory demyelinating polyneuropathy (CIDP), primary immunodeficiency, hepatitis, primary immunodeficiency, and human immunodeficiency virus (HIV). These products are taken by separating plasma from human blood and screening it for quality. Depending on the medication, you may be given your dose via multiple injection sites at the same time. Normally, SCIg is tolerated fairly well by most patients. Swelling is a common reaction at the injection site. If the needle was placed incorrectly, you may feel itching and burning as well. You should report any side effects to your doctor or the treatment center right away. Depending on the side effect, your doctor may be able to treat the symptoms or switch the medication you are given.
Zofran (both IV & Inj)
Zofran is intended for patients who are about to have chemotherapy or surgery. As an infusion or injection, it can decrease vomiting and nausea. You can take this medication before you get anesthesia or up to two hours afterward. When you are given Zofran for chemotherapy, your infusion provider will typically give it to you 30 minutes before your treatment starts. Then, you will have two follow-up doses at four hours and eight hours later. If you are over the age of 12, you can receive a dose of Zofran for postoperative nausea. This dose will be administered over the course of 30 seconds to five minutes. For children between the ages of 1 month and 12 years, a smaller dose of Zofran can be given. Zofran can occasionally cause side effects in patients. If you experience fever, diarrhea, or headaches, you should talk to your infusion provider right away. In addition, you shouldn’t use this product if you have a hypersensitivity to any component of it.
Gammaked
If you suffer from primary immunodeficiency, idiopathic thrombocytopenic purpura (ITP), or chronic inflammatory demyelinating polyneuropathy (CIDP), Gammaked could be a good choice for you. This medication is given as an immune globulin (Ig) injection. It can be used to prevent relapse and enhance neuromuscular abilities in CIDP patients. If you have ITP, Gammaked can help to improve your platelet counts. You may also take it before surgery to prevent excessive bleeding. This medication can also be given to improve primary immunodeficiency in patients who are 2 years old and older. Gammaked can be given intravenously or subcutaneously. It can’t be given as an injection if you suffer from ITP or CIDP. You can only get Gammaked as an injection if you suffer from primary immunodeficiency. These SubQ injections can be given in up to eight spots at a time on your body, and you will repeat these injections each week.
Prolia
Prolia was created for postmenopausal women who have a high risk of developing a fracture. It is especially useful for women who can’t use other osteoporosis medications or who have had an unsuccessful experience with them. In addition, it can also be used by men who are suffering from bone loss. This medication is a targeted treatment. It can stop bone-removing cells in their tracks, so they can’t hurt your bones. You shouldn’t take this medication if you are pregnant or have low calcium levels. Prolia is typically given once every six months. If you miss your expected dose, you should take it as soon as possible afterward. Afterward, you should schedule your next dose for six months later. To take this medication, you need to take vitamin D and calcium supplements. While there is a chance of side effects while taking Prolia, there is also a risk of fractures if you don’t take it. Before your treatment, you should carefully discuss the risks and benefits of Prolia with your doctor.
Vitamin B12
Vitamin B12 injections typically consist of cyanocobalamin or hydroxocobalamin. Both of these medications can help to increase your blood levels of B12. If you are deficient in B12 for any reason, your doctor may prescribe B12 injections on a regular basis. This vitamin is needed by your body for creating red blood cells and DNA. It is also important for your brain function. Because your liver can store extra vitamin B12 for years, it can take a long time before you become deficient. People may become deficient if they follow a vegan or vegetarian diet. You may also become deficient because of anemia, alcoholism, immune system disorders, diseases that affect your small intestine, and atrophic gastritis If you are deficient in vitamin B12, your doctor may prescribe these shots every two to three months for the rest of your life. Depending on the underlying cause, you may be given B12 injections in conjunction with other medications as well.

CAINFUSION TREATMENTS

Actemra
Actemra is a type of prescription medicine that is typically given to adults who have moderate to severe rheumatoid arthritis (RA). It is only given after you have already tried at least one other disease modifying antirheumatic drug (DMARD). If the DMARD didn’t work for you, you can talk to your doctor about whether Actemra could be used as an alternative treatment. This medication is also used for people who have giant cell arteritis (GCA), active polyarticular juvenile idiopathic arthritis (PJIA), active systemic juvenile idiopathic arthritis (SJIA), or systemic sclerosis-associated interstitial lung disease (SSc-ILD). If the patient suffers from PJIA or SJIA, they must be at least 2 years old to take the drug. When used for SSc-ILD, Actemra can help to slow down the progression of decline in your lung function. Actemra works by changing how your immune system functions. Because of this, you are more likely to get an infection or have a serious infection. You should always tell your medical provider about any infections before you start taking Actemra.
Adakveo
If you suffer from sickle cell disease, you may be prescribed Adakveo. By taking this medication patients can reduce the likelihood of having a pain crisis by 45 percent. To be eligible for this medication, you must be over the age of 16. This medication works by making certain blood cells and blood vessels less sticky. It essentially attaches to P-selectin, which is known to play a major role in blockages. Once Adakveo attaches to this sticky factor, it can prevent some cells from connecting. As a result, you are less likely to experience pain crises. Adakveo is given as a 30-minute infusion each month. During the initial month, you will receive an extra infusion after just two weeks. Following the first month, patients will switch to monthly treatments. If you are taking hydroxyurea or similar treatments, you may still be able to take Adakveo as well. You should talk to your doctor to see if you can take Adakveo in conjunction with other medications.
Aldurazyme
Aldurazyme is designed to treat mucopolysaccharidosis I (MPS I). It can treat adults and children who have the Hurler and Hurler-Scheie forms of the disease. In addition, Aldurazyme can also treat people who have moderate or severe cases of the Scheie form of the disease. Depending on your medical history and other factors, you may be pretreated with antihistamines, antipyretics, or both. The entire treatment will take about three to four hours to complete. Then, you will repeat your infusion each week. Antihistamines and antipyretics are given because there is a potential for infusion reactions. If you do have a reaction, you should alert the medical staff right away. They may stop the treatment or give you medication to alleviate your symptoms. Infusion reactions were found in almost a third of patients in clinical trials. In general, the most common infusion reactions were raised body temperature, rashes, headaches, and flushing.
Aralast NP
Aralast NP can boost the level of Alpha1 protein in your lungs and blood. Normally, the treatment is given once a week to help your body replace this key protein. It takes a doctor or nurse just 15 minutes to give this medication intravenously. Normally, the body creates Alpha1 protein to protect your lungs. It circulates throughout your bloodstream and prevents inflammation after you inhale irritants or develop an infection. When someone has low or absent levels of this important protein, it can lead to lung damage and emphysema. Often, an Alpha1 deficiency is genetic. A genetic mutation can make it impossible for your body to develop adequate levels of this protein. If you don’t have enough of this protein, you will likely develop lung damage between the ages of 20 and 50 years old. Roughly one out of every 3,000 to 5,000 people suffer from Alpha1 protein deficiency. With the right medication, it is possible to manage this disease and prevent lung complications.
Cerezyme
As a type of enzyme replacement therapy (ERT), Cerezyme is useful for people who suffer from Gaucher disease type 1. It is intended for people who are over the age of 2 who have developed bone disease, anemia, an enlarged liver, low blood platelet count, or an enlarged spleen from Gaucher disease type 1. Originally released in 1994, it is the only ERT that has a long-term track record of safety and efficacy. While Cerezyme is generally safe, some patients have developed severe allergic reactions after taking the drug. If you notice symptoms, like chest discomfort, rapid heart rate, flushing, or hives, you should seek immediate medical care. About 15% of patients develop antibodies and an immune response to Cerezyme during their initial year of therapy. When this happens, the individual has a higher chance of having an allergic reaction. Because of this, your doctor may test you for antibodies to detect this problem as early as possible.
Benlysta
Monoclonal antibody. Treats lupus. Blocks B-cell activation. Reduces symptoms like joint pain and fatigue.
Gammagard
Intravenous immunoglobulin. Treats immunodeficiency disorders. Boosts antibodies, enhancing the immune system to fight infections.
Gammaplex
ntravenous immunoglobulin. Treats primary immunodeficiency. Supplies antibodies, enhances immunity, and prevents infections in patients with deficiencies.
Krystexxa
Treats chronic gout. Converts uric acid to a soluble form. Reduces pain and inflammation.
Octagam
Intravenous immunoglobulin. Treats immunodeficiency disorders. Infused to boost antibodies, strengthening the immune system against infections.
Radicava
Intravenous immunoglobulin. Treats immunodeficiency disorders. Infused to boost antibodies, strengthening the immune system against infections.
Simponi ARIA
 Treats rheumatoid arthritis. Monoclonal antibody. Targets tumor necrosis factor (TNF), reducing inflammation and joint damage.
Stelara IV & SQ
 Treats psoriasis, psoriatic arthritis, Crohn’s disease. Intravenous or subcutaneous injection. Targets interleukins, modulating immune response.
Vyepti
Monoclonal antibody. Prevents migraine attacks. Administered intravenously. Targets calcitonin gene-related peptide (CGRP), reducing frequency and severity.
Benlysta
Benlysta was the first Food and Drug Administration (FDA) approved medication for lupus and lupus nephritis. It can be given subcutaneously or intravenously (IV) if you suffer from active lupus nephritis or lupus. The Benlysta IV version is approved for children 5 and up who have lupus. Once someone is taking this infusion, it can significantly decrease their lupus activity. Many patients notice improvements in the function of their immune system and muscles. It can also help your skin, joints, and mouth. This biology therapy isn’t a steroid, and you can take it with other lupus medications. It works by focusing on the underlying cause of the disease. Benlysta can reduce your disease activity and flare-ups. Plus, this medication can decrease your steroid doses by 25 percent. Patients are typically given Benlysta every two weeks for the first three infusions. After that, the one-hour infusions are given every four weeks.
Cinqair
As a type of enzyme replacement therapy (ERT), Cerezyme is useful for people who suffer from Gaucher disease type 1. It is intended for people who are over the age of 2 who have developed bone disease, anemia, an enlarged liver, low blood platelet count, or an enlarged spleen from Gaucher disease type 1. Originally released in 1994, it is the only ERT that has a long-term track record of safety and efficacy. While Cerezyme is generally safe, some patients have developed severe allergic reactions after taking the drug. If you notice symptoms, like chest discomfort, rapid heart rate, flushing, or hives, you should seek immediate medical care. About 15% of patients develop antibodies and an immune response to Cerezyme during their initial year of therapy. When this happens, the individual has a higher chance of having an allergic reaction. Because of this, your doctor may test you for antibodies to detect this problem as early as possible.
Bivigam
Intravenous immunoglobulin. Treats primary immunodeficiency. Boosts immune system. Prevents infections. Infused to replace antibodies.
Gammagard Liquid
Intravenous immunoglobulin. Treats immunodeficiency. Liquid form for convenient administration. Boosts immune response against infections.
IV Steroids
Intravenous immunoglobulin. Treats immunodeficiency. Liquid form for convenient administration. Boosts immune response against infections.
LEQEMBI
Monoclonal antibody. Treats neuromyelitis optica spectrum disorder (NMOSD). Targets B cells, reducing relapses and symptoms.
Orencia
 Immunomodulator. Treats rheumatoid arthritis. Blocks T-cell activation, reducing inflammation and joint damage. Subcutaneous or intravenous administration.
Remicade
Monoclonal antibody. Treats autoimmune disorders like rheumatoid arthritis. Blocks inflammation by targeting tumor necrosis factor (TNF).
Soliris
Monoclonal antibody. Treats rare blood disorders like paroxysmal nocturnal hemoglobinuria. Inhibits complement system, preventing cell destruction.
Tysabri (TOUCH center certified)
 Monoclonal antibody. Treats multiple sclerosis. TOUCH center certified. Modulates immune system, reducing relapses and disease progression.
Vyvgart.
As of my last knowledge update in January 2022, I don’t have information on a medication called “Vyvgart.”
Bivigam
Bivigam is unique because it helps people who have primary humoral immunodeficiency (PI) disorders. Most people fight off diseases using their immune system. When someone’s immune system lacks the right defenses for fighting off diseases, they are said to have a PI disorder. This medication consists of human immune globulin. When you are given Bivigam, your infusion nurse or physician will decide how fast to give the infusion to you based on your comfort and body weight. During the initial infusion, your response will be closely monitored. If your body handles the infusion dose well, then the infusion rate will be increased after 10 minutes have passed. Then, the infusion speed can be increased every 20 minutes. You will generally have to receive another infusion every three to four weeks. Bivigam is made by collecting and processing human plasma. The immune globulin is removed from plasma using a centrifuge. Afterward, it goes through extensive quality and safety controls before it is turned into an infusion.
Cinryze
Cinryze is used to treat hereditary angioedema (HAE) in children, which can prevent attacks from happening later in life. Starting as early as the age of 6, children can take this medication to decrease the severity and frequency of HAE attacks. Released in 2008, Cinryze is known as the first C1 esterase inhibitor (C1-INH). The Food and Drug Administration (FDA) approved this drug for treating children, adults, and teenagers for HAW. Pediatric patients can take this drug to limit the amount of acute treatment they need to take. Normally, people naturally produce C1-INH protein in their bodies. With HAE, people don’t have enough of this key protein. As a result, the body releases plasma kallikrein and bradykinin. These proteins can cause your small blood vessels to release fluid in areas of your body. You end up suffering from pain and swelling. With Cinryze, you can take the drug intravenously every three to four days to prevent future attacks.
Entyvio
Monoclonal antibody. Treats inflammatory bowel diseases. Targets gut inflammation. Reduces symptoms, promotes healing, and prevents complications.
Gammagard S/D (IgA <1 mcg/mL)
Intravenous immunoglobulin. Treats immunodeficiency. Low IgA content reduces risk of allergic reactions. Boosts immunity.
IVIG (e.g. Gamunex-C)
Intravenous immunoglobulin. Treats immunodeficiency. Low IgA content reduces risk of allergic reactions. Boosts immunity.
Ocrevus
 Monoclonal antibody for multiple sclerosis. Loading dose, then maintenance. Targets B cells, slows disease progression, reduces relapses.
Privigen
Intravenous immunoglobulin. Treats immunodeficiency disorders. Provides antibodies to enhance immune response against infections.
Rituxan
 Monoclonal antibody. Treats non-Hodgkin’s lymphoma, rheumatoid arthritis. Targets B cells, suppressing disease activity and inflammation.
Solu-Medrol
Corticosteroid. Treats inflammatory conditions. Rapid relief by suppressing immune response, reducing inflammation, and swelling.
Uplizna
 Monoclonal antibody. Treats neuromyelitis optica spectrum disorder (NMOSD). Reduces relapses by targeting B cells.
Zofran
Antiemetic medication. Treats nausea and vomiting. Blocks serotonin, alleviating symptoms caused by surgery, chemotherapy, or radiation.

Expert Guidance, Support, and Motivation at Every Stage

We acknowledge that managing health conditions can be a source of stress for patients, particularly when facing infusion therapy for the first time. Our dedicated team places great importance on each patient’s well-being and the success of their treatment. We strive to create a supportive environment, offering personalized attention at every phase of their treatment journey

We know you have a choice when it comes to your infusion provider.

To book an appointment, contact us online or call us directly at (559)-431-4007

COLLABORATION ACROSS THE CONTINUUM OF CARE

To help ensure patients get access to the best therapy in the best setting for them, Infusion for Health partners with various providers involved. We work with treating physicians to help them drive positive patient outcomes from infusion therapy. We educate hospitals and health systems who don’t understand the unique infusion needs of patients with complex, chronic conditions and coordinate with them to serve as an alternative setting when they lack bandwidth to serve these patients. We build relationships with pharmaceutical and biotech companies to reduce patient treatment barriers and stay abreast of new therapies in development.